82.56
Livanova Plc stock is traded at $82.56, with a volume of 452.29K.
It is up +0.05% in the last 24 hours and up +5.33% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$82.52
Open:
$82.52
24h Volume:
452.29K
Relative Volume:
0.57
Market Cap:
$4.54B
Revenue:
$1.43B
Net Income/Loss:
$107.13M
P/E Ratio:
42.62
EPS:
1.9372
Net Cash Flow:
$161.04M
1W Performance:
-1.27%
1M Performance:
+5.33%
6M Performance:
+28.18%
1Y Performance:
+76.90%
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LIVN
Livanova Plc
|
82.56 | 4.54B | 1.43B | 107.13M | 161.04M | 1.9372 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
World Cardiopulmonary Bypass MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Price to earnings forward of LivaNova Plc – SWB:LIA - TradingView
Price to sales forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC balances neuromodulation growth with cardiac surgery challenges - ad-hoc-news.de
(LIVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq- - ad-hoc-news.de
Enterprise value to revenue forward of LivaNova PLC – NASDAQ:LIVN - TradingView
Price to sales forward of LivaNova Plc – LSX:A14156 - TradingView
Price to book forward of LivaNova PLC – NASDAQ:LIVN - TradingView
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors - simplywall.st
LivaNova stock hits 52-week high at 84.3 USD - Investing.com
LivaNova Plc Change Of Registered Office - marketscreener.com
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Sahm
Livanova stock initiated at Hold by Freedom Capital on growth outlook - Investing.com Nigeria
LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study - Medical Product Outsourcing
LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2500 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000E Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth-Defensive Index - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000 Growth Benchmark - marketscreener.com
(LIVN) Risk Channels and Responsive Allocation - Stock Traders Daily
LivaNova Plc Hits New 52-Week High of USD 82.62 - MarketsMojo
LivaNova PLC (LIVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh - TradingView
LivaNova Plc Actuals & Estimates (NASDAQ:LIVN) - TradingView
LivaNova reports improved OSA outcomes with PolySync programming - MSN
LIVN Forecast — Price Target — Prediction for 2027 - TradingView
LIA Forecast — Price Target — Prediction for 2027 - TradingView
LivaNova stock hits 52-week high at 81.08 USD - Investing.com UK
LivaNova stock hits 52-week high at 81.08 USD By Investing.com - Investing.com Nigeria
How New OSA PolySync Data Could Shape LivaNova’s (LIVN) Neuromodulation Investment Narrative - Sahm
LivaNova to announce second-quarter 2026 results on Aug 5 - scanx.trade
Press Release: LivaNova to Announce Second-Quarter 2026 Results - Moomoo
Beyond the Balance Sheet: LivaNova's Q2 to Test Med-Tech's Pulse - BriefGlance
LivaNova demonstrates 84.5% cumulative response rate with PolySync programming in OSPREY study for obstructive sleep apnea - MSN
LIVN Maintained by Keybanc -- Price Target Raised to $92.00 - GuruFocus
LivaNova PLC (LIVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
LivaNova PLC (LIVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LivaNova PLC (LIVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LivaNova PLC (LIVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LivaNova Plc Hits New 52-Week High of USD 80.77 - MarketsMojo
LivaNova PLC (LIVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Livanova Plc Stock (LIVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SCHERMERHORN TODD C | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
13,105 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
11,270 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Sale |
80.19 |
1,200 |
96,228 |
9,584 |
| PODLOGAR SUSAN M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
6,128 |
| Barry James Christopher | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
8,404 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
2,965 |
0 |
7,122 |
| KOZY WILLIAM A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
5,681 |
0 |
38,248 |
| Enxing Seng Stacy | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
15,793 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
| Zurbay Donald | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
2,560 |
0 |
2,560 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):